Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge-Reference-Cited by-同舟云学术

Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge

Published:2007-05 Issue:1 Volume:362 Page:139-150
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Tompkins S. Mark,Lin Yuan,Leser George P.,Kramer Kari A.,Haas Debra L.,Howerth Elizabeth W.,Xu Jie,Kennett Mary J.,Durbin Russell K.,Durbin Joan E.,Tripp Ralph,Lamb Robert A.,He Biao

Publisher

Elsevier BV

Subject

Virology

Reference51 articles.

1. A simian virus 5 (SV5) P/V mutant is less cytopathic than wild-type SV5 in human dendritic cells and is a more effective activator of dendritic cell maturation and function;Arimilli;J. Virol.,2006

2. Epidemiologic studies of latent virus infections in captive monkeys and baboons: II. Serologic evidence of myxovirus infections with special reference to SV5;Atoynatan;Am. J. Epidemiol.,1969

3. Kennel cough complex: confirmation and analysis of the outbreak in Japan;Azetaka;Nippon Juigaku Zasshi,1988

4. Viruses recovered from laboratory dogs with respiratory disease;Binn;Proc. Soc. Exp. Biol. Med.,1967

5. Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates;Bukreyev;J. Virol.,2005

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A J Paramyxovirus-vectored HIV vaccine induces humoral and cellular responses in mice;Vaccine;2024-04

2. Recombinant parainfluenza virus 5 expressing clade 2.3.4.4b H5 hemagglutinin protein confers broad protection against H5Ny influenza viruses;Journal of Virology;2024-03-19

3. Intranasal vaccine for Lyme disease provides protection against tick transmitted Borrelia burgdorferi beyond one year;npj Vaccines;2024-02-15

4. Intranasal parainfluenza virus type 5 (PIV5)–vectored RSV vaccine is safe and immunogenic in healthy adults in a phase 1 clinical study;Science Advances;2023-10-27

5. Combined intranasal and intramuscular parainfluenza 5-, simian adenovirus ChAdOx1- and poxvirus MVA-vectored vaccines induce synergistically HIV-1-specific T cells in the mucosa;Frontiers in Immunology;2023-07-17